Added γ-oryzanol boosted anti-inflammatory effects of canola oil in adult subjects with type 2 diabetes: a randomized controlled clinical trial - Nikooyeh, Bahareh; Zargaraan, Azizollaah; Ebrahimof, Samira; Kalayi, Ali; Zahedirad, Maliheh; Yazdani, Hootan; Rismanchi, Marjan; Karami, Taher; Khazraei, Marzieh; Jafarpour, Ali; Neyestani, Tirang R. (European journal of nutrition, 2024)
Keywords: Adult; adults; Anti-Inflammatory Agents - pharmacology; Anti-Inflammatory Agents - therapeutic use; biomarkers; blood serum; C-reactive protein; Canola; canola oil; Chemistry; Chemistry and Materials Science; Clinical trials; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Female; Helianthus; Helianthus annuus; Humans; Immunoglobulin A; Inflammation; interleukin-6; issues and policy; Male; malondialdehyde; NCT; NCT05271045; noninsulin-dependent diabetes mellitus; Nutrition; Original Contribution; Oxidative stress; Phenylpropionates; Rapeseed Oil; Statistical analysis; Sunflower Oil; Vegetable oils; γ-Interferon; Type 2 diabetes; Oxidative stress; Sunflower oil; γ-oryzanol; Canola oil; Clinical trial; Immunity